Formulation Optimization of Synchronous Release of Neiyixiao Compound Sustained-release Dropping Pills and Investigation on Its Releasing Mechanism
ZHANG Yu,PENG Chun-mei,TANG Qin,XU Xiao-yu,ZHANG Ji-fen
2012-01-01
Abstract:Objective To optimize the formulation of Neiyixiao Compound Sustained-release Dropping Pills which could release active compositions at synchronic rate and to investigate its releasing mechanism.Methods The Doehlert design and response surface method were used to optimize the formulation.Four independent variables,the ratio of drug and matrix(X1),the content of ethylcellulose(X2),PEG 6000(X3),and stearic acid in matrix(X4) were investigated.The interval of released amount was established as response.DDsolver software was used to fit releasing models.Results The optimal formulation was as following: the ratio of drug and matrix was 1∶12,the content of ethylcellulose,PEG 6000,and stearic acid in matrix were 12%,30%,and 20%,respectively.Under the simulated gastrointestinal pH conditions,the values of similarity factor(f2*) of ferulic acid and ligustrazine,ferulic acid and tetrahydropalmatine,and ligustrazine and tetrahydropalmatine were 53.37,56.17,and 57.85,respectively.The release profile of ferulic acid complied with first-order kinetics and Higuchi equations,and those of ligustrazine and tetrahydropalmatine were in accordance with Baker-Lonsdale and Ritger-Peppas equations.Conclusion The optimal formulation of compound sustained-release dropping pills makes it possible that each component could get to sustained-release synchronously.The release mechanism is diffusion.